Shaohua Chen Selected Research

gamma chain CD3 antigen

5/2011	Change in expression pattern of TCR-CD3 complex in patients with multiple myeloma.
1/2011	Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shaohua Chen Research Topics

Disease

39	Neoplasms (Cancer) 07/2022 - 04/2005
17	Leukemia 03/2021 - 09/2000
15	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2022 - 09/2000
13	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2022 - 04/2010
12	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 07/2022 - 11/2010
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2022 - 09/2000
8	Acute Promyelocytic Leukemia 01/2021 - 04/2005
7	Nasopharyngeal Carcinoma 09/2020 - 05/2010
6	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2014
6	Allergic Rhinitis 12/2016 - 01/2012
5	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 09/2013
5	Myeloid Leukemia (Leukemia, Myelocytic) 10/2020 - 09/2000
4	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 02/2014
4	Inflammation (Inflammations) 01/2021 - 12/2011
4	Shock 04/2020 - 09/2013
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2013 - 02/2010
3	T-Cell Lymphoma (Lymphoma, T Cell) 07/2022 - 03/2015
3	Multiple Myeloma 03/2022 - 05/2011
3	Lymphoma (Lymphomas) 02/2022 - 04/2010
3	Pathologic Complete Response 01/2022 - 04/2009
3	Infections 09/2021 - 12/2011
3	Carcinoma (Carcinomatosis) 12/2020 - 02/2014
3	Secondary Hyperparathyroidism 11/2020 - 01/2018
3	Communicable Diseases (Infectious Diseases) 09/2020 - 02/2014
3	Non-alcoholic Fatty Liver Disease 09/2015 - 09/2008
3	Obesity 01/2010 - 09/2008
2	Stomach Neoplasms (Stomach Cancer) 06/2022 - 01/2021
2	Adenocarcinoma of Lung 02/2022 - 01/2022
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 03/2014
2	Glioma (Gliomas) 01/2021 - 01/2021
2	Neoplasm Metastasis (Metastasis) 01/2020 - 05/2019
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2014
2	Diabetes Mellitus 11/2019 - 11/2019
2	Anemia 11/2019 - 11/2019
2	Hypoalbuminemia 11/2019 - 11/2019
2	Hypertensive Nephropathy 11/2019 - 11/2019
2	Arteriovenous Fistula 11/2019 - 11/2019
2	Renal Insufficiency (Renal Failure) 05/2018 - 01/2018
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2016 - 08/2009
2	Carcinogenesis 02/2015 - 01/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2014 - 06/2014
2	Blast Crisis (Blast Phase) 01/2014 - 09/2013
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2014 - 01/2014
2	Colitis 05/2012 - 09/2010
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2011 - 05/2011

Drug/Important Bio-Agent (IBA)

25	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 01/2002
17	Proteins (Proteins, Gene)FDA Link 06/2022 - 05/2006
12	AntigensIBA 09/2020 - 01/2002
11	Biomarkers (Surrogate Marker)IBA 07/2022 - 11/2016
8	Biological ProductsIBA 03/2021 - 07/2013
6	Immunoglobulins (Immunoglobulin)IBA 08/2022 - 10/2018
6	Messenger RNA (mRNA)IBA 01/2021 - 04/2009
5	RNA (Ribonucleic Acid)IBA 07/2022 - 02/2015
5	AllergensIBA 02/2022 - 09/2013
5	Small Interfering RNA (siRNA)IBA 12/2019 - 11/2010
4	Long Noncoding RNAIBA 02/2022 - 09/2014
4	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 01/2010
3	Transcription Factors (Transcription Factor)IBA 12/2022 - 02/2015
3	Carrier Proteins (Binding Protein)IBA 01/2020 - 10/2013
3	Pharmaceutical PreparationsIBA 12/2019 - 11/2019
3	Imatinib Mesylate (Gleevec)FDA Link 11/2019 - 04/2010
3	CalciumIBA 11/2019 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 10/2017 - 09/2013
3	3' Untranslated Regions (3' UTR)IBA 12/2016 - 12/2012
3	SYBR Green IIBA 04/2012 - 11/2010
2	Competitive Endogenous RNAIBA 02/2022 - 01/2022
2	Indicators and Reagents (Reagents)IBA 01/2022 - 02/2014
2	Immune Checkpoint ProteinsIBA 01/2022 - 04/2020
2	Dendrimers (Dendrons)IBA 12/2021 - 07/2018
2	matrigelIBA 01/2021 - 10/2016
2	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2018
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	LigandsIBA 01/2020 - 09/2013
2	AminesIBA 12/2019 - 12/2019
2	Transferrin (beta 2 Transferrin)IBA 12/2019 - 07/2018
2	MethyltransferasesIBA 12/2019 - 09/2015
2	Peptides (Polypeptides)IBA 01/2019 - 10/2005
2	CollagenIBA 10/2016 - 05/2011
2	Inosine Triphosphate (ITP)IBA 10/2016 - 08/2009
2	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 09/2000
2	CytokinesIBA 06/2015 - 12/2011
2	obatoclaxIBA 12/2014 - 06/2014
2	NF-kappa B (NF-kB)IBA 11/2014 - 01/2014
2	CopperIBA 01/2014 - 09/2013
2	Interleukin-10 (Interleukin 10)IBA 01/2012 - 12/2011
2	gamma chain CD3 antigenIBA 05/2011 - 01/2011
2	Therapeutic UsesIBA 05/2010 - 03/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010 - 03/2008
1	LectinsIBA 08/2022

Therapy/Procedure

13	Immunotherapy 01/2022 - 01/2012
13	Therapeutics 12/2021 - 04/2010
5	Drug Therapy (Chemotherapy) 01/2021 - 10/2012
4	Radiotherapy 01/2020 - 05/2010
4	Hematopoietic Stem Cell Transplantation 11/2016 - 04/2011
3	Parathyroidectomy 11/2020 - 01/2018
2	Autologous Transplantation 05/2018 - 01/2018
2	Aftercare (After-Treatment) 03/2017 - 03/2008
2	Bioelectric Energy Sources 01/2014 - 09/2013
2	Ligation 01/2014 - 07/2013
2	Transplantation 01/2009 - 03/2008